Dr. Eleftheria Kalogera, MD

Dr. Kalogera practices at Baptist Health Baptist Hospital in Miami, Florida, part of Baptist Health South Florida.

Dr. Kalogera's NPI, 1568726727, was assigned on July 2, 2012. Dr. Kalogera graduated from University of Athens in 2008. Dr. Kalogera holds Florida license ME149656.

Dr. Kalogera's primary practice is Baptist Health Baptist Hospital, at 8900 N Kendall Dr, Miami, FL 33176 in Miami-Dade County. The practice phone is (786) 596-1960.

Dr. Kalogera's primary practice is Baptist Health Baptist Hospital in Miami, Florida, part of Baptist Health South Florida. Dr. Kalogera is also affiliated with South Miami Hospital. The medical group on file is BHMG Gynecologic Oncology. Dmand AI also links Dr. Kalogera to 1 more hospital and 1 breast imaging center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kalogera practices, 4 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Kalogera's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dr. Kalogera is board certified in gynecologic oncology by the American Board of Obstetrics and Gynecology. Dmand AI has Dr. Kalogera's licenses on file in 2 states: Florida and Minnesota.

Dmand AI lists hysterectomy and ovarian cyst among the conditions Dr. Kalogera treats.

CMS data shows 172 Medicare services from Dr. Kalogera across 4 procedure codes in 2024, for 82 Medicare patients. Medicare paid $14,464 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 82 Medicare patients who saw Dr. Kalogera in 2024. The largest group is 75 to 84, with 41 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 17% are also on Medicaid. Their average risk score is 1.66, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kalogera's median patient age at 55, with 99% women.

In 2019, Dr. Kalogera wrote 46 Medicare Part D claims. Every claim was for a generic drug. They cover 3 drugs, with $2,331 in total drug cost. In 2016, CMS named 22 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Kalogera for performance year 2024, reported as part of a group. Dr. Kalogera accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kalogera as offering telehealth. CMS counts 16 procedures of removal of the uterus by Dr. Kalogera, more than 90% of the clinicians it reports for that procedure.

Dmand AI links 33 papers to Dr. Kalogera, published from 2011 to 2024. 2017 was the busiest year, with 3. The most frequent topics are Ovarian Neoplasms, Gynecologic Surgical Procedures and Autophagy. Dr. Kalogera has published most often in Gynecol Oncol. Dr. Kalogera's most frequent co-authors are Sean C. Dowdy, MD, Jamie N. Bakkum-Gamez, MD and William A. Cliby, MD.

CMS Open Payments shows 14 general payments to Dr. Kalogera from 6 drug and device companies from 2018 to 2024. Food and beverage make up the largest share, 100% of the total. Intuitive Surgical, Inc. paid the most, $253.

Dr. Kalogera graduated from University of Athens in 2008.

Dr. Kalogera is in network with 12 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 7. Check the plan with the practice before a visit.